| 1.06 0.02 (1.92%) | 02-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 3.66 | 1-year : | 5.34 |
| Resists | First : | 3.13 | Second : | 4.57 |
| Pivot price | 1.22 |
|||
| Supports | First : | 0.8 | Second : | 0.66 |
| MAs | MA(5) : | 1.08 |
MA(20) : | 1.34  |
| MA(100) : | 2.98 |
MA(250) : | 24.57 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 5.8 |
D(3) : | 6.5 |
| RSI | RSI(14): 44.2 |
|||
| 52-week | High : | 120.95 | Low : | 0.7 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ IVF ] has closed above bottom band by 30.0%. Bollinger Bands are 65% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.1 - 1.11 | 1.11 - 1.11 |
| Low: | 1.03 - 1.03 | 1.03 - 1.04 |
| Close: | 1.05 - 1.06 | 1.06 - 1.07 |
INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered in Sarasota, FL.
Wed, 11 Feb 2026
INVO Fertility (IVF) Secures Patent for Enhanced INVOcell Device - GuruFocus
Wed, 11 Feb 2026
INVO Fertility Announces Patent Issuance for Modified INVOcell® Device - The Manila Times
Wed, 11 Feb 2026
New patent backs fertility device that grows embryos inside the body - Stock Titan
Wed, 04 Feb 2026
INVO Fertility, Inc. Announces Strategic Outlook for Growth and Strengthened Financial Position - Quiver Quantitative
Wed, 04 Feb 2026
INVO Fertility reports strongest fundamental position in company history - Investing.com
Thu, 29 Jan 2026
Looking Into INVO Fertility Inc's Recent Short Interest - Benzinga
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 15 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 3.5 (%) |
| Held by Institutions | 11.5 (%) |
| Shares Short | 41 (K) |
| Shares Short P.Month | 95 (K) |
| EPS | -286.52 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -4.47 |
| Profit Margin | 0 % |
| Operating Margin | -93.1 % |
| Return on Assets (ttm) | -48.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 22.6 % |
| Gross Profit (p.s.) | 0.17 |
| Sales Per Share | 0.45 |
| EBITDA (p.s.) | -0.48 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | -0.24 |
| Price to Sales | 2.31 |
| Price to Cash Flow | -2.1 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|